1999
DOI: 10.1002/(sici)1097-0282(1999)51:1<79::aid-bip9>3.0.co;2-w
|View full text |Cite
|
Sign up to set email alerts
|

The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0

Year Published

2002
2002
2014
2014

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 29 publications
(17 citation statements)
references
References 31 publications
0
17
0
Order By: Relevance
“…The role of oxidative stress has also been studied and investigators report that oxidative stress inhibits GSH [37] which can lead to enhanced virus replication [38]. Oxidative stress can also inhibit mucus antiproteases [39] that regulate the trypsin like serine proteases which cleaves influenza hemagluttinin, effectively enhancing its ability to spread and more readily infect epithelial cells [40,41]. Our study proposes an additional mechanism for this phenomenon.…”
Section: Discussionmentioning
confidence: 75%
“…The role of oxidative stress has also been studied and investigators report that oxidative stress inhibits GSH [37] which can lead to enhanced virus replication [38]. Oxidative stress can also inhibit mucus antiproteases [39] that regulate the trypsin like serine proteases which cleaves influenza hemagluttinin, effectively enhancing its ability to spread and more readily infect epithelial cells [40,41]. Our study proposes an additional mechanism for this phenomenon.…”
Section: Discussionmentioning
confidence: 75%
“…The substitution Ile-328→Thr, which is conserved in canine viruses, could have been selected to ensure the required cleavage of precursor HA0 into HA1 and HA2. This could be achieved by optimizing the Gln/Glu-X-Arg− recognition site for a canine protease like tryptase Clara (15) or by increasing the ability of HA0 to compete with mucus protease inhibitors known to be present in the respiratory tract (16).…”
Section: Significancementioning
confidence: 99%
“…The induction of influenza virus infectivity by host cell proteases is strictly regulated by inhibitors of the serine proteases such as human mucus protease inhibitor (MPI) in the upper respiratory tract (Kido et al, 1999) and pulmonary surfactant (Kido et al, 1993) in the lower respiratory tract. MPI accounts for 70-90% of the protease-inhibitory capacity of normal bronchial secretions.…”
Section: Discussionmentioning
confidence: 99%